Europe’s TCR Therapy Scene Gains Traction with €40M Series B
Swedish firm Anocca's fundraising is the first major venture capital round to go to a…
26/07/2021 - 5 minutes
Trends & News
British Diagnostics Biotech Becomes Social Enterprise After Acquisition
UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by…
30/07/2021 - 4 minutes
Trends & News
Microbiome Medicines Could Power Up CAR-T Cell Therapies
The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings…
28/07/2021 - 5 minutes
In Depth
Tracking Covid-19 Cases with Wastewater Testing
Researchers have been using DNA testing technology to detect traces of the SARS-CoV-2 virus behind…
- 5 minutes
ADVERTISEMENT
Do you want to remove this advert? Become a member!
What's New
MoreThe Underlying Scientific Issues Making Biotech Startups Fail
Biotech startups rely heavily on the science behind their products. There are a series of…
26/07/2021 - 5 minutes
What the EU’s Single-Use Plastics Ban Means for the Bioplastics Industry
A European directive banning a range of single-use plastics came into law this month. How…
21/07/2021 - 10 minutes
Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene
Muna Therapeutics debuted with the Danish biotech sector’s biggest-ever Series A round earlier this month.…
20/07/2021 - 4 minutes
How to Protect Your Intellectual Property as a Biotech Startup
Biotechs always start with great scientific ideas, but if you can’t protect them, you can’t…
19/07/2021 - 9 minutes
Multi-Million UK Life Sciences Initiative Welcomed By VC Firms
Biotech venture capital firms across Europe have warmly received the launch of a €235M (£200M)…
16/07/2021 - 4 minutes
From Our Partners
View More
Sponsored
by Precision for Medicine
Using the Full Potential of Circulating Tumor Cells for Oncology Clinical Trials
Sponsored
by Scientist.com
Using AI to Select the Right Disease Model for Cancer Drug Development
Sponsored
by Takara Bio
How Human-induced Pluripotent Stem Cells are Revolutionizing Drug Discovery
Sponsored
by Vetter
How a CDMO Alliance Sets New Standards for Drug Development and Commercialization
Download our industry reports
View all our reports
